Barrier role of ABC family of proteins in human placenta;Barierowa rola białek nadrodziny ABC w łożysku ludzkim

Ginekologia Polska

Volumn 82, Issue 1, 2011, Pages 56-63

  Kozłowska Rup, Danuta ^a   Czekaj, Piotr ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

ABC transporter; Breast Cancer Resistance Protein (BCRP); Multidrug Resistance Protein (MRP); P glycoprotein; Placenta; Placental barrier

Indexed keywords

EID: 79551599535     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Marin J, Briz O, Serrano M. A Review on the Molecular Mechanisms Involved in the placental Barrier for Drugs. Curr Drug Deliv. 2004, 1, 275-289.
2. Kovo M, Golan A. In Vitro Models Using the Human Placenta to Study Fetal Exposure to Drugs. Clin Med Reprod Health. 2008, 2, 15-24.
3. Syme M, Paxton J, Keelan J. Drug Transfer and Metabolism by the Human Placenta. Clin Pharmacokinet. 2004, 43, 487-514.
4. Szałek E, Grześkowiak E. Bezpieczeństwo farmakoterapii w okresie cia{ogonek}ży. Farmacja Wsp. 2008, 1, 109-115.
5. Webster W, Freeman J. Is drug safe in pragnancy? Reprod Toxicol. 2001, 15, 619-629.
6. Holcberg G, Tsadkin-Tamir M, Sapir O, [et al.]. New Aspects in Placental Drug Transfer. IMAJ. 2003, 5, 873-876.
7. Myllynen P, Immonen E, Kummu M, [et al.]. Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin. Drug Metab. Toxicol. 2009,5, 1483-1499.
8. Ganapathy V, Prasad P. Role of transporters in placental transfer of drugs. Toxicol Appl Pharmacol. 2005, 207, Suppl 2, 381-387.
9. St-Pierre M, Ugele B, Gambling L, [et al.]. Mechanisms of drug transfer across the human placenta - a workshop report. Placenta. 2002, 23, Suppl A, 159-164.
10. Evseenko D, Paxton J, Keelan J. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos. 2007, 35, 595-601.
11. van der Aa E, Peereboom-Stegeman J, Noordhoek J, [et al.]. Mechanisms of drug transfer across the placenta. Pharm World Sci. 1998, 20, 139-148.
12. Ganapathy V, Prasad P, Ganapathy M, [et al.]. Placental Transporters Relevant to Drug Distribution across the Maternal-Fetal Interface. J Pharmacol Exp Ther. 2000, 294, 413-420.
13. Rahi M. Role of membrane transporters, P-Glycoprotein and MRP1, in the placental transfer of drugs. With Special Reference to Saquinqvir and Quetiapine. Annales Universitatis Turkuensis 2009. University of Turku, Finland.
14. Zaremba M. Lekooporność w nowotworach wieku dziecie{ogonek}cego. Cze{ogonek}ść I - białka zwia{ogonek}zane z lekoopornościa{ogonek}. Onkol Pol. 2005, 2, 57-61.
15. Unadkat J, Dahlin A, Vijay S. Placental drug transporters. Curr Drug Metab. 2004, 5, 125-131.
16. Litman T, Druley T, Stein W, [et al.]. From MDR to MXR: New understanding of multi-drug resistance systems, their properties and clinical significance. Cell Mol Life Sci. 2001, 58, 931-959.
17. Schinkel A, Jonker J. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev. 2003, 55, 3-29.
18. Ceckova-Novotna M, Pavek P, Staud F. P-glycoprotein in the placena: Expression, localization, regulation and function. Reprod Toxicol. 2006, 22, 400-410.
19. Vähäkangas K, Myllynen P. Drug transporters in the human blood-placental barrier. Br J Pharmacol. 2009, 158, 665-678.
20. Maeda K, Sugiyama Y. Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. Drug Metab Pharmacokinet. 2008, 23, 223-235.
21. Behravan J, Piquette-Miller M. Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opin Drug Metab Toxicol. 2007, 3, 819-830.
22. Mao Q. BCRP/ABCG2 in the Placenta: Expression, Function and Regulation. Pharm Res. 2008, 25, 1244-1255.
23. Evseenko D, Murthi P, Paxton J, [et al.]. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J. 2007, 21, 3592-3605.
24. Wang H, Zhou L, Gupta A, [et al.]. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab. 2006, 290, 798-807.
25. Włoch S, Pałasz A, Kamiński M. Czynny i bierny transport leków w łożysku ludzkim. Ginekol Pol. 2009, 80, 772-777.
26. Weier N, He S, Li X, [et al.]. Placental drug disposition and its clinical implications. Curr Drug Metab. 2008, 9, 106-121.
27. Gulati A, Gerk P. Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy. J Pharm Sci. 2009, 98, 2317-2335.
28. Gedeon C, Behravan J, Koren G, [et al.]. Transport of Glyburide by Placental ABC Transporters: Implications in Fetal Drug Exposure. Placenta. 2006, 27, 1096-1102.
29. Hemauer S, Patrikeeva S, Nanovskaya T, [et al.]. Role of human placental apical membrane transporters in the efflux of glyburide,rosiglitazone, and metformin. Am J Obstet Gynecol. 2010, 202, 383.e1-7.
30. Petrovic V, Teng S, Piquette-Miller M. Regulation of drug transporters during infection and inflammation. Mol Interv. 2007, 7, 99-111.